177 related articles for article (PubMed ID: 23925934)
1. Cholera toxin subunit B peptide fusion proteins reveal impaired oral tolerance induction in diabetes-prone but not in diabetes-resistant mice.
Presa M; Ortiz AZ; Garabatos N; Izquierdo C; Rivas EI; Teyton L; Mora C; Serreze D; Stratmann T
Eur J Immunol; 2013 Nov; 43(11):2969-79. PubMed ID: 23925934
[TBL] [Abstract][Full Text] [Related]
2. The cholera toxin B subunit is a mucosal adjuvant for oral tolerance induction in type 1 diabetes.
Bregenholt S; Wang M; Wolfe T; Hughes A; Baerentzen L; Dyrberg T; von Herrath MG; Petersen JS
Scand J Immunol; 2003 May; 57(5):432-8. PubMed ID: 12753499
[TBL] [Abstract][Full Text] [Related]
3. Oral administration of cholera toxin B-insulin conjugates protects NOD mice from autoimmune diabetes by inducing CD4+ regulatory T-cells.
Ploix C; Bergerot I; Durand A; Czerkinsky C; Holmgren J; Thivolet C
Diabetes; 1999 Nov; 48(11):2150-6. PubMed ID: 10535448
[TBL] [Abstract][Full Text] [Related]
4. B lymphocytes treated in vitro with antigen coupled to cholera toxin B subunit induce antigen-specific Foxp3(+) regulatory T cells and protect against experimental autoimmune encephalomyelitis.
Sun JB; Czerkinsky C; Holmgren J
J Immunol; 2012 Feb; 188(4):1686-97. PubMed ID: 22250081
[TBL] [Abstract][Full Text] [Related]
5. B lymphocytes promote expansion of regulatory T cells in oral tolerance: powerful induction by antigen coupled to cholera toxin B subunit.
Sun JB; Flach CF; Czerkinsky C; Holmgren J
J Immunol; 2008 Dec; 181(12):8278-87. PubMed ID: 19050244
[TBL] [Abstract][Full Text] [Related]
6. Glutamic acid decarboxylase epitope protects against autoimmune diabetes through activation of Th2 immune response and induction of possible regulatory mechanism.
Gong Z; Pan L; Le Y; Liu Q; Zhou M; Xing W; Zhuo R; Wang S; Guo J
Vaccine; 2010 May; 28(24):4052-8. PubMed ID: 20406664
[TBL] [Abstract][Full Text] [Related]
7. Peptide-MHC class II dimers as therapeutics to modulate antigen-specific T cell responses in autoimmune diabetes.
Masteller EL; Warner MR; Ferlin W; Judkowski V; Wilson D; Glaichenhaus N; Bluestone JA
J Immunol; 2003 Nov; 171(10):5587-95. PubMed ID: 14607967
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy of autoimmune diabetes by nasal administration of tandem glutamic acid decarboxylase 65 peptides.
Wang H; Yang J; Jin L; Feng J; Lu Y; Sun Y; Li T; Cao R; Wu J; Fan H; Liu J
Immunol Invest; 2009; 38(8):690-703. PubMed ID: 19860582
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cell-mediated induction of mucosal cytotoxic responses following intravaginal immunization with the nontoxic B subunit of cholera toxin.
Luci C; Hervouet C; Rousseau D; Holmgren J; Czerkinsky C; Anjuère F
J Immunol; 2006 Mar; 176(5):2749-57. PubMed ID: 16493030
[TBL] [Abstract][Full Text] [Related]
10. Oral Administration of Silkworm-Produced GAD65 and Insulin Bi-Autoantigens against Type 1 Diabetes.
Liu B; Yue Y; Yang Y; Jin Y
PLoS One; 2016; 11(1):e0147260. PubMed ID: 26783749
[TBL] [Abstract][Full Text] [Related]
11. Protection against autoimmune diabetes by silkworm-produced GFP-tagged CTB-insulin fusion protein.
Meng Q; Wang W; Shi X; Jin Y; Zhang Y
Clin Dev Immunol; 2011; 2011():831704. PubMed ID: 21765853
[TBL] [Abstract][Full Text] [Related]
12. Suppression of hyperglycemia in NOD mice after inoculation with recombinant vaccinia viruses.
Dénes B; Yu J; Fodor N; Takátsy Z; Fodor I; Langridge WH
Mol Biotechnol; 2006 Nov; 34(3):317-27. PubMed ID: 17284779
[TBL] [Abstract][Full Text] [Related]
13. Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes.
Chen C; Lee WH; Yun P; Snow P; Liu CP
J Immunol; 2003 Jul; 171(2):733-44. PubMed ID: 12847240
[TBL] [Abstract][Full Text] [Related]
14. Presence of diabetes-inhibiting, glutamic acid decarboxylase-specific, IL-10-dependent, regulatory T cells in naive nonobese diabetic mice.
You S; Chen C; Lee WH; Brusko T; Atkinson M; Liu CP
J Immunol; 2004 Dec; 173(11):6777-85. PubMed ID: 15557171
[TBL] [Abstract][Full Text] [Related]
15. Prevention of type I diabetes transfer by glutamic acid decarboxylase 65 peptide 206-220-specific T cells.
Kim SK; Tarbell KV; Sanna M; Vadeboncoeur M; Warganich T; Lee M; Davis M; McDevitt HO
Proc Natl Acad Sci U S A; 2004 Sep; 101(39):14204-9. PubMed ID: 15381770
[TBL] [Abstract][Full Text] [Related]
16. Suppression of diabetes in non-obese diabetic (NOD) mice by oral administration of a cholera toxin B subunit-insulin B chain fusion protein vaccine produced in silkworm.
Gong Z; Jin Y; Zhang Y
Vaccine; 2007 Feb; 25(8):1444-51. PubMed ID: 17113687
[TBL] [Abstract][Full Text] [Related]
17. Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+CD25+ and Foxp3-CD25- CD4+ regulatory T cells.
Sun JB; Raghavan S; Sjöling A; Lundin S; Holmgren J
J Immunol; 2006 Dec; 177(11):7634-44. PubMed ID: 17114433
[TBL] [Abstract][Full Text] [Related]
18. Protection Against
Pan X; Ke H; Niu X; Li S; Lv J; Pan L
Front Immunol; 2018; 9():1003. PubMed ID: 29867978
[TBL] [Abstract][Full Text] [Related]
19. Genetic fusion of human insulin B-chain to the B-subunit of cholera toxin enhances in vitro antigen presentation and induction of bystander suppression in vivo.
Sadeghi H; Bregenholt S; Wegmann D; Petersen JS; Holmgren J; Lebens M
Immunology; 2002 Jun; 106(2):237-45. PubMed ID: 12047753
[TBL] [Abstract][Full Text] [Related]
20. Oral tolerance induction by mucosal administration of cholera toxin B-coupled antigen involves T-cell proliferation in vivo and is not affected by depletion of CD25+ T cells.
George Chandy A; Hultkrantz S; Raghavan S; Czerkinsky C; Lebens M; Telemo E; Holmgren J
Immunology; 2006 Jul; 118(3):311-20. PubMed ID: 16827892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
